Editoria e Media
Burgeoning Sales of Dilation Drops to Bolster Ophthalmic Eye Drops Market Growth: Future Market Insights Study
According to the World Health Organization, around 60% of patients in the U.S. are prescribed with antibiotic eye drops and approximately 10 million people across the globe undergo cataract surgery each year. Furthermore, around 7.7 million people in the U.S. were affected with diabetic retinopathy. Hence, demand for dilation eye drops is increasing with the mounting cases of eye surgery each year. Based on the aforementioned factors, the global ophthalmic eye drops market is expected to witness staggering growth throughout the forecast period.
https://www.futuremarketinsights.com/reports/sample/rep-gb-13140
FMI has profiled some of the prominent market players providing ophthalmic eye drops that include Novartis AG, Bausch & Lomb, Akorn Inc., Biomedica, Advacare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN Group, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Adelphi Healthcare Packaging, Aptar Group Inc., Amcor PLC, and Gerresheimer AG among others. Prominent manufacturers are deploying a slew of expansion strategies, ranging from product innovation to strategic collaboration & partnerships to maintain the lead in the industry,
In February 2021 , Bausch & Lomb, global leading eye health company and Nicox, an ophthalmic company announced that VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, received regulatory approval from Ministry of Food and Drug Safety in South Korea . The product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma in the U.S. and other states.
Also, Ocuphire Pharma Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders announced the results of ORION-1 Phase 2 clinical trial evaluating the safety & efficacy of Nyxol in glaucoma and presbyopia.
Furthermore, in July 2020 , Alcon, the global leader in eye care dedicated to helping people see, announced the U.S. Food and Drug Administration approval for PAZEO, an olopatadine hydrochloride ophthalmic eye care solution for the patients in the U.S.
https://www.futuremarketinsights.com/customization-available/rep-gb-13140
Future Market Insights, in its new offering, provides an unbiased analysis of the ophthalmic eye drops market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the ophthalmic eye drops market with a detailed segmentation on the basis of drug class (anesthetic drops, dilation drops, glaucoma drops, steroid drops, antibiotic drops, and others (antihistamine, and lubricants tear drops)), indication (dry eye, eye allergy, glaucoma, eye infection, retinal disorders (macular degeneration, diabetic retinopathy and others), uveitis, and others), drug formulation (with preservative and preservative free), container type (single dose container and multiple-dose container), distribution channel (institutional sales, hospitals, community clinics, ophthalmic clinics, public health agencies, veterinary hospitals & clinics, retail sales, and drug stores), across major regions ( North America , Latin America , Europe , East Asia , South Asia , Oceania, and Middle East & Africa )
https://www.futuremarketinsights.com/ask-question/rep-gb-13140
Eye Infections Treatment Market: The eye infections treatment market study by Future Market Insights (FMI) provides a deeper insights on the new trends while incorporating the impact of ongoing trends, and growth & restraining factors during the forecast period of 2021 to 2031. Market dynamics have been presented on the basis of prominent drivers, trends and opportunities prevailing across key geographies for the aforementioned decade.
Ophthalmic Viscosurgical Devices Market: ESOMAR-certified market analysis and consulting company Future Market Insights (FMI) provides insights driving ophthalmic viscosurgical devices market demand in latest report. Additionally, to find the effect of COVID-19 on the ophthalmic viscosurgical devices market in general, the study monitor global ophthalmic viscosurgical devices sales in 20+ high-growth markets and addresses their end-user in particular.
Eye Socket Implants Market: In its latest study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers in-depth insights on key factors that influence the demand for eye socket implants. The report covers global demand for Fish powder in more than 20 high potential markets, in addition to an in-depth analysis of the impact of COVID-19 on the global eye socket implants market.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai , and has delivery centers in the UK, U.S. and India . FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Abhishek Budholiya
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai ,
United Arab Emirates
sales@futuremarketinsights.com
press@futuremarketinsights.com
https://www.futuremarketinsights.com/
https://www.futuremarketinsights.com/reports/ophthalmic-eye-drops-market
https://www.futuremarketinsights.com/press-release/skincare-market
Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg